English 
Spanish 
3 min read
Novamed, located in the Industrial Pole of Manaus, aims to expand the production of pills and create jobs
Last Wednesday (the 25th), Novamed announced an investment of BRL 50 million between 2021 and 2022, aimed at expansion in the city of Manaus. The factory's objective is to expand the production of pills, so that, by 2023, up to 900 pills will be generated jobs in the Amazon.
In a meeting, the expansion project was exposed by representatives of the NC Group – owner of the pharmaceutical company EMS and the company Novamed de Manaus – to representatives of the State Secretariat for Economic Development, Science, Technology and Innovation (Sedecti) and other bodies.
In addition, at the meeting, Novamed announced that production will expand from 1 billion and 100 million pills per month to 1 billion and 400 million/month.
- R$20 million in debt and 20 months without salaries: Why did investors give up on buying Avibras?
- America's new $1,5 billion tallest tower faces turmoil, construction delayed
- Elon Musk proposes $20 trillion alternative to tunnel that will connect New York and London in just 54 minutes
- Important highway (BR) will be renovated and selection to fill job vacancies on the project already has a start date
The statements were made during an event promoted by Novamed at the Manaus plant, located on the AM-010 highway, Km 22, North Zone of the capital. In addition to what was previously mentioned, the company also spoke about the social role of industry pharmaceutical; of donations made to Manaus in the midst of peaks of Covid-19 pandemic; collection values; the incorporation of Novamed by EMS, which should be completed by 2023; among other topics.
There was also a guided tour of the manufacturing park, which, according to Sedecti, is the only one completely robotized in the Industrial Pole of Manaus (PIM).
Renata Alves defends the incorporation of Novamed by EMS
According to the legal and Risks and Compliance director of the NC group, Renata Alves, EMS currently operates in Amazonas through the company Novamed, and the idea behind the incorporation is that the consumer is able to identify that the medicine purchased by him in a pharmacy is manufactured by the pharmaceutical industry present in the state of Amazonas.
The director also states that the intention is to extend EMS knowledge to the state, in order to further strengthen the brand and its presence, in addition to providing the expansion of its social action projects and the fulfillment of its social function in the country.
In addition to the company's representatives, the event was also attended by the head of Sedecti's Investment Attraction and Foreign Trade Department, Jeibi Medeiros, representing the minister, Angelus Figueira; the superintendent of the Manaus Free Trade Zone (Suframa), Algacir Polsin; among other invited participants.
Under this bias, Jeibi Medeiros declared that Novamed is a factory that impresses with its processes, numbers and modern environment full of technology. For him, the visit was of great interest, as it allowed a better knowledge of the work that the company has been carrying out in the city of Manaus and also of the way in which the investment is being applied, since it is a company that has the incentives taxes granted by the Government of Amazonas.
Algacir Posin, in turn, opined that the investment to incorporate Novamed into EMS will be of great importance, given that the entire production of medicines and pill capsules will be taken to Manaus, thus expanding the generation of jobs and revenues in the region.
About Novamed
The company was inaugurated in 2014 and consists of one of the five largest and most modern solid medicine factories in the world, in addition to being the first company to produce medicines in the Manaus Free Trade Zone.
Novamed is the only factory that has a fully robotic raw material weighing system, with the manufacturing process completely automated, with electronic documentation and without the use of paper. The available equipment corresponds to the most modern in the world.
